(60) suggest that serum CEA levels exceeding twice the threshold value can be used to differentiate malignant from benign tumors, whereas CA-19-9 levels above the cut-off could be used to identify borderline tumors. The gene discussed is CEACAM5; the disease is benign neoplasm.